Related Experiment Video

Updated: Jul 26, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

Researchers exploring implications of minimal residual cancer

Gail McBride

    Journal of the National Cancer Institute
    |November 17, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

    Published on: July 28, 2020

    Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
    04:45

    Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

    Published on: May 10, 2021

    Related Experiment Videos

    Last Updated: Jul 26, 2026

    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
    09:57

    Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

    Published on: March 5, 2018

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies
    07:15

    A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing (Neo)adjuvant Therapies

    Published on: July 28, 2020

    Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way
    04:45

    Intraoperative Assessment of Resection Margins in Oral Cavity Cancer: This is the Way

    Published on: May 10, 2021

    Related Concept Videos

    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

    Articles linked to this work by shared authors, journal, and citation graph.

    Anal cancer burden among people with HIV across US states, DC, and major metro areas.

    Journal of the National Cancer Institute·2026

    Benchmarking female breast cancer survival in africa, Central and South america, and asia (SURVCAN-3).

    Journal of the National Cancer Institute·2026

    Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-Derived external control arms.

    Journal of the National Cancer Institute·2026

    Endocrine therapy in early-stage estrogen Receptor-Low breast cancer: a systematic review and Meta-Analysis.

    Journal of the National Cancer Institute·2026

    Development and validation of a predictive model of aromatase inhibitor-induced arthralgia among patients with early breast cancer.

    Journal of the National Cancer Institute·2026

    Leiomyosarcoma survival across anatomical sites identifies high- and low-risk patient groups to inform clinical trial design.

    Journal of the National Cancer Institute·2026

    Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026

    Outcomes of target therapies for pediatric BRAF V600-mutant low-grade gliomas: A systematic review and meta-analysis.

    Neuro-oncology advances·2026

    Research on serine hydroxymethyltransferase 2 mechanisms in malignant tumor development and progression.

    PeerJ·2026

    Titanium dioxide nanoparticle-modified screen-printed electrode for erlotinib determination.

    ADMET & DMPK·2026

    Advances in FGF/FGFR Signaling: Implications for Disease and Therapy.

    MedComm·2026

    Recurrence distance analysis for clinical target volume optimization in glioblastoma.

    Clinical and translational radiation oncology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us